Palonosetron Hydrochloride Injection, Solution
Product Images NDC 0781-3415

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Palonosetron Hydrochloride (NDC 0781-3415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Palonosetron Nova 01

FDA Label Image

Palonosetron Nova 02

FDA Label Image

Palonosetron Nova 03

FDA Label Image

Palonosetron Nova 04

FDA Label Image

Palonosetron Nova 05

Palonosetron Nova 05
This is a product description for Palonosetron HCl injection, used intravenously. It comes in a single-dose vial of 5mL. The solution is sterile and contains 0.25mg/mL of Palonosetron HCl. Each mL of the solution has palonosetron hydrochloride equivalent to 0.05 g palonosetron. The solution also contains other ingredients such as mannitol, edetate disodium dihydrate, sodium citrate dihydrate, trisodium monohydrate, and water for injection. This medicine is for injection only and should be discarded if unused. The medication needs to be protected from freezing and stored at a controlled temperature. More information about dosage and administration can be found in the package insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.